Congenital hereditary endothelial dystrophy (CHED) is a rare inherited corneal endothelial disorder presenting at or shortly after birth with bilateral, diffuse corneal clouding.
It is one of the small handful of conditions that must be actively and urgently distinguished from congenital glaucoma in any infant with cloudy corneas — a distinction with enormous practical stakes, since the two conditions require entirely different management, in the case of glaucoma genuinely time-sensitive.
Genetics
CHED is now understood to represent a spectrum related to mutations in SLC4A11, with autosomal recessive inheritance being the form most commonly encountered and generally the more severe, presenting at birth with dense, opaque corneal clouding.
Older classification schemes described a milder, autosomal dominant form with later onset and slower progression, though modern genetic understanding has clarified that the great majority of clinically significant cases seen in practice are the recessive, congenital-onset form.
Pathophysiology
The underlying defect impairs normal corneal endothelial pump function from birth, preventing the endothelium from adequately clearing fluid from the stroma the way a normally functioning endothelial layer does.
The result is diffuse, bilateral stromal and epithelial edema present from the earliest days of life, giving the cornea a hazy, ground-glass appearance rather than its normal clarity.
Unlike acquired endothelial diseases such as Fuchs dystrophy, discussed in its own dedicated article on this site, which develop from progressive endothelial cell loss over decades, CHED reflects a fundamental developmental failure of normal endothelial function present from the start.
All-fit Slit-Lamp Adapter
Record and share exactly what you see at the slit lamp. One adapter fits any slit lamp or surgical microscope — and any smartphone.
From Choroida — the team behind this siteClinical Presentation
- Bilateral, diffuse corneal clouding present at birth or developing within the first weeks of life, often symmetric between the two eyes
- Corneal thickness is significantly increased (unlike the normal or near-normal corneal thickness typically seen in congenital glaucoma, where the primary structural change is corneal enlargement and Descemet membrane tears rather than diffuse edema)
- Photophobia and tearing, though generally less pronounced than the marked photophobia and blepharospasm classically associated with congenital glaucoma
- Nystagmus, often developing secondary to the poor, blurred visual input the child receives from the clouded corneas during the critical period of visual development
- Notably normal intraocular pressure and normal corneal diameter — this is the single most important distinguishing feature from congenital glaucoma, and confirming it is the central task of the initial evaluation
Distinguishing CHED From Congenital Glaucoma
Congenital glaucoma produces corneal clouding through a fundamentally different mechanism — elevated intraocular pressure causing corneal enlargement (buphthalmos) and breaks in Descemet’s membrane (Haab’s striae) that allow aqueous to enter and edematize the stroma — and is accompanied by an enlarged corneal diameter, elevated intraocular pressure on measurement, and often more prominent photophobia, tearing, and blepharospasm than typically seen in CHED.
Because congenital glaucoma is a genuine emergency requiring prompt surgical intervention to prevent irreversible optic nerve damage, any infant presenting with cloudy corneas needs intraocular pressure measurement and careful corneal diameter assessment (often requiring examination under anesthesia given how difficult a reliable, cooperative exam is in an infant) as an urgent priority, before CHED can be comfortably assumed as the explanation.
Differential Diagnosis of Neonatal Corneal Clouding
- Congenital glaucoma — elevated intraocular pressure, corneal enlargement, Haab’s striae, discussed in its own dedicated article on this site; the critical alternative diagnosis to exclude urgently
- Birth trauma (forceps injury) — typically unilateral or asymmetric, with a clear history of a difficult or instrumented delivery, and often vertical or oblique Descemet membrane tears on careful exam
- Sclerocornea — a congenital anomaly in which the cornea takes on an opaque, sclera-like quality, generally more peripheral and with a different overall appearance than the diffuse, central-predominant clouding of CHED, discussed in its own dedicated article on this site
- Metabolic and storage disorders (mucopolysaccharidoses and others) — generally accompanied by other systemic findings that help distinguish them from an isolated corneal dystrophy, and worth considering when corneal clouding is accompanied by additional developmental or systemic abnormalities
- Congenital corneal infection (herpes simplex, rubella) — a relevant maternal and perinatal history usually points toward this category rather than an inherited dystrophy
Management
Because CHED significantly impairs visual input from birth, there is a real and urgent risk of severe amblyopia if the corneal clouding is not addressed during the critical period of early visual development, making prompt intervention — rather than a “wait and see” approach — generally appropriate once the diagnosis is established and congenital glaucoma has been confidently excluded.
Corneal transplantation, traditionally penetrating keratoplasty, though endothelial keratoplasty techniques are increasingly being explored and used in appropriately selected pediatric cases, is the definitive treatment, performed as early as reasonably feasible given the amblyogenic stakes.
However, pediatric corneal transplantation carries its own well-recognized surgical and long-term challenges, including a higher rejection risk than adult keratoplasty and the need for aggressive, coordinated amblyopia management after surgery.
Genetic counseling for the family addresses recurrence risk given the syndrome’s typically autosomal recessive inheritance, and long-term, coordinated pediatric ophthalmic follow-up — addressing not just the corneal graft itself but the amblyopia, refractive error, and any associated nystagmus — is essential for optimizing the child’s ultimate visual outcome, continuing well beyond the immediate postoperative period into later childhood.
Document what you see
Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.
From Choroida — the team behind this siteReferences
- Kumar A, Bhattacharjee S, Prakash DR, Sadanand CS. Genetic analysis of two Indian families affected with congenital hereditary endothelial dystrophy: two novel mutations in SLC4A11. Molecular Vision.
- Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies — edition 2. Cornea.
- American Academy of Ophthalmology. Basic and Clinical Science Course, Section 6: Pediatric Ophthalmology and Strabismus.
